Sherritt Blocks Requisition-But December's 55% Deal Could Decide Control

Sherritt's procedural block delays, but does not end, the fight

Sherritt's response looks like a boardroom win on the surface, but it mostly shifts the battle to December. Under the CBCA, Sherritt says the requisition is rendered ineffective because the company had already announced a December 15, 2026 meeting, set an October 30, 2026 record date, and notified the Toronto Stock Exchange. Even so, the Board said it will convert that meeting into a combined annual and special meeting and put Kyma's proposals before shareholders. The procedural shortcut is blocked; the contest is not.

Why December matters

This is not a routine proxy dispute. The bigger issue is a term sheet that could give Gillon economic control if fully exercised. Sherritt says the warrant is exercisable for enough shares that Gillon would own 55% of the Common Shares then issued and outstanding immediately after exercise. If that path advances, the meeting may become less about choosing a direction and more about responding to a financing outcome already in motion.

Kyma is making that concern explicit, calling the December schedule "choreography" and pressing for disclosure of transaction-related incentives and conflicts. The Board may argue it kept the process alive until December, but the more pressing question is whether shareholders will be deciding strategy or ratifying terms already being negotiated.

The control question turns on financing, not just procedure

The requisition dispute keeps the corporate governance fight visible, but the more important issue is who can bring capital to Sherritt and on what terms.

The Gillon warrant is the main lever

The Gillon warrant is not just financing interest. It is a control-leaning instrument. If exercised in full, Gillon would own 55% of the Common Shares then issued and outstanding. Management also expects the exercise price to be at a discount to the May 15, 2026 closing price, while the parties remain in a 120-day period of exclusive negotiations. That setup matters because it ties together three sensitive issues at once: dilution, discount pricing, and exclusivity.

The deal is still far from certain. The private placement remains subject to definitive documentation, customary conditions, and regulatory approvals, including approval of the Toronto Stock Exchange. Until those conditions are clearer, the market is weighing a possible control transaction rather than a completed rescue.

Sherritt's balance-sheet pressure raises the stakes

Sherritt says it continues to operate with constrained liquidity and a material uncertainty that may cast doubt on its ability to continue as a going concern. The operating backdrop is also weaker: metals refining has stopped at the Fort Saskatchewan refinery, direct participation in joint venture activities in Cuba has been suspended, and restart costs have been pushed higher by expensive sulphur.

That context helps explain why a majority-control warrant matters so much. Bulls may see a distressed company getting a rare source of capital. Bears may see minority equity being diluted in a deal that gives one investor decisive influence.

Kyma's mixed stake shapes the real power dynamic

That pushes the fight away from procedure and into the capital structure. The key question is not only who has voting power, but who has the largest economic interest if the company is restructured.

Kyma has both debt and equity exposure

Kyma says it owns approximately one-third of Sherritt's outstanding notes and approximately 15% of its common shares, and that no other stakeholder has a greater current economic interest across Sherritt's capital structure. That mix matters. As a large noteholder, Kyma has an interest in recovery and flexibility. As a significant common shareholder, it also has exposure to equity upside.

That is why the dispute over governance is tied so closely to the financing process. Kyma has accused the Board of favouring Gillon by granting a 120-day period of exclusive negotiations before a broader marketing process. The company has not confirmed that framing, but in a distressed issuer with constrained liquidity, perceived bias in the process can matter to shareholders and creditors alike.

The practical implication is simple: even if Kyma does not win immediate board seats, it can still influence the outcome if the Gillon path hardens first. If the warrant structure leads to majority control on exercise, other stakeholders may find themselves negotiating from a weaker position.

What matters most before the December meeting

The fight has shifted from procedure to positioning. The most important developments from here are likely to be changes in stakes, progress in approvals, and signs that the operating strain is worsening.

1) Kyma's position before the record date

Watch whether Kyma changes its position before the October 30, 2026 record date. It currently holds approximately one-third of Sherritt's outstanding notes and approximately 15% of its common shares, and it has already challenged the process by demanding disclosure of transaction-related incentives and conflicts. Adding to its notes or shares would signal confidence in its leverage. Reducing exposure could signal the opposite.

2) Whether the Gillon term sheet becomes credible

The second watchpoint is whether the term sheet starts to look like a workable financing path rather than a bargaining position. The warrant carries a nine-month warrant exercise period, and the parties are still working through legal, regulatory and commercial complexities. One useful update would be fresh confirmation that the Department of State and Department of Treasury do not object to continued talks, because that would address one of the clearest execution concerns.

3) Whether operating pressure forces the timetable forward

The third signpost is operational strain. Sherritt still reports constrained liquidity, and the company has flagged much higher input costs around any restart. If conditions worsen, the need for outside capital could intensify-and with it, the odds that a Gillon-style recap becomes the main outcome before shareholders meet.

For investors, that is the core setup. Sherritt now looks less like a standard proxy contest and more like a control-and-dilution story driven by financing need, exclusivity, and the balance-sheet pressure captured in the company's going-concern disclosure.